News
-
Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data
January 6, 2026 -
Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS)
December 4, 2025 -
Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S.
December 2, 2025 -
Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion
November 5, 2025 -
Aclarion Wins "Rising Star" at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH
October 22, 2025 -
Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst
October 14, 2025 -
Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference
October 13, 2025 -
Aclarion to Present at the LD Micro Main Event XIX
October 9, 2025 -
Aclarion Honored as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH
October 7, 2025 -
Aclarion Presents at LSI Europe '25 Highlighting Nociscan Technology and Key Value Drivers
October 1, 2025